Artal Group’s Nanobiotix NBTX Stock Holding History

Artal Group’s Portfolio NBTX Stock Details NBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,000,000	Closed	-$8.75M	–	106
2023 Q3	$8.75M	Hold	1,000,000	–	–	0.38%	42
2023 Q2	$5.07M	Hold	1,000,000	–	–	0.16%	66
2023 Q1	$3.52M	Hold	1,000,000	–	–	0.21%	70
2022 Q4	$3.67M	Hold	1,000,000	–	–	0.2%	70
2022 Q3	$3.54M	Hold	1,000,000	–	–	0.15%	73
2022 Q2	$3.8M	Hold	1,000,000	–	–	0.2%	69
2022 Q1	$7.44M	Hold	1,000,000	–	–	0.31%	64
2021 Q4	$8.1M	Hold	1,000,000	–	–	0.22%	76
2021 Q3	$11.4M	Hold	1,000,000	–	–	0.25%	77
2021 Q2	$13.8M	Hold	1,000,000	–	–	0.28%	73
2021 Q1	$15M	Hold	1,000,000	–	–	0.27%	79
2020 Q4	$16.5M	Buy	+1,000,000	New	+$17.2M	0.35%	66

Other funds holding NBTX

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Artal Group's NBTX Position: Q4 2023 in Review

Artal Group sold out of Nanobiotix (NBTX) in Q4 2023, closing a stake of 1,000,000 shares — an estimated $8.75M sold.

Artal Group first reported a position in NBTX in Q4 2020 and held it in 12 quarters. The position peaked at $16.5M in Q4 2020. 12 funds tracked by Wall St. Rank hold NBTX as of Q4 2023.

Artal Group reported no remaining Nanobiotix position as of Q4 2023 after selling out during the quarter.
Artal Group sold 1,000,000 Nanobiotix shares in Q4 2023, an estimated $8.75M.
Artal Group first reported a position in Nanobiotix in Q4 2020 and held it in 12 quarters.
Artal Group's Nanobiotix position peaked at $16.5M in Q4 2020.
12 funds tracked by Wall St. Rank held Nanobiotix as of Q4 2023.

Based on Artal Group's 13F filing for Q4 2023, filed 9 Feb 2024.